Jaruratanasirikul Somchit, Sriplung Hutcha
Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.
J Med Assoc Thai. 2006 Sep;89(9):1396-9.
To study the growth pattern of children affected with thyrotoxicosis.
A retrospective study of growth data of 40 patients with thyrotoxicosis diagnosed at prepuberty or at early puberty was conducted. All patients were evaluated for height and weight every 3-6 months. Height and weight were transformed to standard deviation score (SDS) to account for differences of age and sex.
At the time of diagnosis, the patients were slightly underweight for height (weight SDS -0.27 +/- 1.24, height SDS -0.06 +/- 1.26). After 1 year of treatment, the average weight gain of the patients was 4.9 +/- 3.1 kg, resulting in becoming relatively overweight for height (weight SDS +0. 32 +/- 1.42, height SDS +0.02 +/- 1.32). At the time of reaching their final height, the patients had an appropriate weight for height (weight SDS +0.06 +/- 0.21, height SDS -0.04 +/- 1.01). The average final height SDS of the patients was -0.04 +/- 1.01. This was at the average of the general population, but was +0.57 +/- 0.48 SDS or +2.85 +/- 1.0 cm greater than their target height (p < 0.01).
Growth of patients with thyrotoxicosis showed the same pattern as in the general population. The final height of thyrotoxicosis patients was averagely +0.57 SDS or +2.85 cm greater than their genetic potential. This could be from the result of secular trend in the general population rather than being the effect of thyrotoxicosis.
研究甲状腺毒症患儿的生长模式。
对40例在青春期前或青春期早期诊断为甲状腺毒症的患者的生长数据进行回顾性研究。所有患者每3 - 6个月进行身高和体重评估。将身高和体重转换为标准差评分(SDS)以考虑年龄和性别的差异。
诊断时,患者身高对应的体重略低于正常(体重SDS -0.27±1.24,身高SDS -0.06±1.26)。治疗1年后,患者平均体重增加4.9±3.1千克,导致身高对应的体重相对超重(体重SDS +0.32±1.42,身高SDS +0.02±1.32)。达到最终身高时,患者身高对应的体重正常(体重SDS +0.06±0.21,身高SDS -0.04±1.01)。患者的平均最终身高SDS为 -0.04±1.01。这处于一般人群的平均水平,但比其目标身高高0.57±0.48 SDS或2.85±1.0厘米(p < 0.01)。
甲状腺毒症患者的生长模式与一般人群相同。甲状腺毒症患者的最终身高平均比其遗传潜力高0.57 SDS或2.85厘米。这可能是一般人群长期趋势的结果,而非甲状腺毒症的影响。